These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34659931)

  • 1. Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment.
    Maksimyan S; Syed MS; Soti V
    Cureus; 2021 Oct; 13(10):e18703. PubMed ID: 34659931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
    Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
    EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
    Rebman AW; Bechtold KT; Yang T; Mihm EA; Soloski MJ; Novak CB; Aucott JN
    Front Med (Lausanne); 2017; 4():224. PubMed ID: 29312942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
    Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
    BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
    Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
    Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
    Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
    Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium.
    Willems R; Verhaeghe N; Perronne C; Borgermans L; Annemans L
    Eur J Public Health; 2023 Aug; 33(4):668-674. PubMed ID: 36972275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
    Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
    mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome.
    Sloupenska K; Koubkova B; Horak P; Hutyrova B; Racansky M; Mares J; Miklusova M; Schovanek J; Zapletalova J; Raska M; Krupka M
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
    Aucott JN; Rebman AW; Crowder LA; Kortte KB
    Qual Life Res; 2013 Feb; 22(1):75-84. PubMed ID: 22294245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure.
    Nilsson K; Skoog E; Jones V; Labbé Sandelin L; Björling C; Fridenström E; Edvinsson M; Mårtensson A; Olsen B
    PLoS One; 2021; 16(3):e0247384. PubMed ID: 33735220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
    Horowitz RI; Freeman PR
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.
    Weinstein ER; Rebman AW; Aucott JN; Johnson-Greene D; Bechtold KT
    Sleep; 2018 May; 41(5):. PubMed ID: 29452400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
    Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
    Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs, utilization and patterns of care following Lyme disease.
    Adrion ER; Aucott J; Lemke KW; Weiner JP
    PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options.
    Talbot NC; Spillers NJ; Luther P; Flanagan C; Soileau LG; Ahmadzadeh S; Viswanath O; Varrassi G; Shekoohi S; Cornett EM; Kaye AM; Kaye AD
    Cureus; 2023 Aug; 15(8):e43112. PubMed ID: 37692614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
    Geebelen L; Lernout T; Kabamba-Mukadi B; Saegeman V; Sprong H; Van Gucht S; Beutels P; Speybroeck N; Tersago K
    Arch Public Health; 2017; 75():42. PubMed ID: 28794875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2.
    Horowitz RI; Freeman PR
    Healthcare (Basel); 2018 Nov; 6(4):. PubMed ID: 30400667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard.
    Crowder LA; Yedlin VA; Weinstein ER; Kortte KB; Aucott JN
    Public Health; 2014 Sep; 128(9):784-91. PubMed ID: 25213101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.